Turkey medical device registration timeline
Source-linked clocksTurkish Medicines and Medical Devices Agency (TİTCK) review clocks and end-to-end planning ranges, using the EU-aligned (I, Is, Im, Ir, IIa, IIb, III) classification system.
| Class / pathway | Review clock | Planning total | With prior approval | Provenance |
|---|---|---|---|---|
| Class I (non-sterile, non-measuring, non-reusable)(Self-declaration, then ÜTS registration) Art. 52(6) of the Tıbbi Cihaz Yönetmeliği: a Class I manufacturer draws up the declaration of conformity itself once the Annex II and III technical documentation is prepared, so no body and no TİTCK review stand between the file and the market | 0 days | 6-9 months | — | Verified |
Turkey Medical Device Registration Process
Step-by-step TİTCK registration process. Total estimated timeline: 6-9 months.
Step 1: Pre-Submission Preparation
1-3 monthsGather technical documentation, quality management system (QMS) records, and clinical data required by TİTCK. Appoint a Turkish Authorized Representative.
Step 2: Application Submission
1-2 weeksSubmit complete registration dossier to TİTCK including device description, risk analysis, and testing reports.
Step 3: Administrative Review
2-4 weeksTİTCK reviews application for completeness. May request additional documents or clarifications.
Step 4: Technical Evaluation
0 daysIn-depth technical assessment of device safety and performance. TİTCK may issue questions.
Step 5: Registration Approval
1-2 weeksUpon successful review, TİTCK issues Turkey market authorization certificate.
- Local Authorized Representative (TR Representative) required for foreign manufacturers
- CE marking accepted for imports; Turkish labeling and UDI requirements apply
- Clinical investigation (Art. 70): TİTCK decides within 10 days whether the study falls under the regulation and whether the file is complete, within 5 days of receiving clarifications, and notifies the authorisation within 45 days of the validity date, extendable by 20 days to consult experts
- Substantial amendments (Art. 75) may be implemented no earlier than 38 days after notification, extendable by 7 days for expert consultation; post-market clinical follow-up studies that add invasive or burdensome procedures need 30 days prior notice (Art. 74)
- Coordinated multi-country assessment (Art. 78): 6 days to settle the coordinating country, 10 days for completeness, a draft report at 26 days, comments to 38 days and the final report at 45 days, extendable by 50 days for Class IIb and III expert consultation, with the single decision notified 5 days later
- Sales-centre certificate for importers/manufacturers: 15 business days, extension 45 business days
Reviewed 2026-08-29. End-to-end totals remain planning estimates.